Skip to main navigation Skip to search Skip to main content

In vitro antimitotic activity and in silico study of some 6-fluoro-triazolo-benzothiazole analogues

  • Naresh Podila
  • , Mithun Rudrapal
  • , Subramanyam Sibbala
  • , Atul R. Bendale
  • , Yanadaiah Palakurthi
  • , Molakpogu Ravindra Babu
  • , Kiran Manda
  • , Renzon Daniel Cosme Pecho
  • , Sreelatha Muddisetti
  • Vignan's Foundation for Science, Technology & Research
  • Lovely Professional University

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

In this work, nine 6-fluoro-triazolo-benzothiazole derivatives were prepared and evaluated for in vitro antimitotic activity. In addition, in silico study was also done using tubulin protein (PDB: 6QQN) by molecular docking method. Results revealed that TZ2 and TZ9 were the most active compounds with antimitotic action opposing the standard drug, aspirin. Results of molecular docking exhibited the inhibitory potential of triazolo-benzothiazole against tubulin protein. The mitotic study indicates the efficacy of triazolo- benzothiazole analogues in inhibiting the proliferation of cancer cells either by promoting microtubule formation or affecting microtubules, thereby preventing microtubule breakdown.

Original languageEnglish
Pages (from-to)887-894
Number of pages8
JournalPharmacia
Volume70
Issue number4
DOIs
StatePublished - 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 1,2,4-triazole
  • Benzothiazole
  • antimitotic activity
  • aspirin
  • cancer
  • mung beans

Fingerprint

Dive into the research topics of 'In vitro antimitotic activity and in silico study of some 6-fluoro-triazolo-benzothiazole analogues'. Together they form a unique fingerprint.

Cite this